MEDICINES EVALUATION AND MONITORING GROUP - CENTRAL NERVOUS-SYSTEM EFFECTS OF PENTAZOCINE

被引：41

作者：

WOOD, AJJ

MOIR, DC

CAMPBELL, C

DAVIDSON, JF

GALLON, SC

HENNEY, E

MCALLION, S

机构：

[1] DUNDEE UNIV,DEPT PHARMACOL & THERAPEUTICS,DUNDEE DD1 4HN,SCOTLAND

[2] ABERDEEN UNIV,DEPT SOCIAL MED,ABERDEEN AB9 1AS,SCOTLAND

[3] MARYFIELD HOSP,DUNDEE,SCOTLAND

来源：

关键词：

D O I：

10.1136/bmj.1.5903.305

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：305 / 307

页数：3

共 8 条

[1] METHOD OF MONITORING DRUGS FOR ADVERSE REACTIONS .1. ALPHA-METHYLDOPA AND HAEMOLYTIC ANAEMIA
COULL, DC
CROOKS, J
DAVIDSON, JF
GALLON, SC
WEIR, RD
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1970, 3 (01) : 46 - &
[2] CROOKS J, 1965, LANCET, V1, P373
[3] HALLUCINATORY EFFECT OF PENTAZOCINE (TALWIN)
DENOSAQUO, N
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 210 (03) : 502 - +
[4] EDISON GR, 1969, NEW ENGL J MED, V281, P447
[5] HART RH, 1969, LANCET, V2, P690
[6] MUNGAVIN JM, 1969, LANCET, V2, P56
[7] TOLERANCE AND DEPENDENCE ON PENTAZOCINE
SANDOVAL, RG
WANG, RIH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (25) : 1391 - &
[8] SCOLAR JC, 1969, LANCET, V1, P32